Trending News
News
News
Icoria to Conduct Biomarker Study for Isis
Icoria will use its proprietary metabolomics platform identify biomarkers of toxicity in animal models.
News
Co-Marketing of Capillary Electrophoresis/Laser-Induced Fluorescence Solutions
Agilent and Picometrics to co-market Picometrics' Laser Induced Fluorescence detection systems combined with Agilent's Capillary Electrophoresis system.
News
deltaDOT Raises £2.3 Million in Latest Round of Financing
deltaDOT has announced that it has completed its private equity funding round, raising £2.3 million (US$4.1 million).
News
Scientists Investigate Drugs for Treatment of Alzheimer's Disease
Scientists have announced that they are investigating a class of pharmaceuticals that may well improve memory function, including those with Alzheimer's disease, and address some of the underlying causes of memory loss rather than today's drugs that simply treat symptoms.
News
NIH to License Odyssey Thera for Molecular Libraries Roadmap Initiative
Odyssey to provide the NIH Chemical Genomics Center with access to proprietary human cell lines with state-of-the-art technology for screening biochemical pathways in living cells
News
Sidmap Provides Metabolic Phenotyping Services
Sidmap signs aggrements with Harvard Medical School's Joslin Diabetes Center and the University of Utah.
News
Renin Co-Crystallization to Speed Cardiovascular Drug Discovery
ActiveSight has announced the addition of renin to their portfolio of "ready-to-go" protein crystals for drug discovery.
News
Gentel® Signs Supply and Marketing License Agreement
GenTel to market and sell the ULS labeling reagents under their brand name PANDEIA™ in diverse kit formats.
News
Collaboration on Peptide Array Synthesizer
Biodesign Institute's Center for BioOptical Nanotechnology is purchasing CombiMatrix' equipment and funding development of the synthesizer.
News
Antibodies by Design and JPT Peptide Technologies Announce Cooperation Agreement
Both parties agree to co-market the rapid generation of monoclonal antibodies by Antibodies by Design and the complementary peptide-based services and products from JPT.
Advertisement